List of Excipients in API DOXORUBICIN HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DOXORUBICIN HYDROCHLORIDE
Excipients in ANDA-approved (generic) drugs containing DOXORUBICIN HYDROCHLORIDE
Detailed excipient profiles for DOXORUBICIN HYDROCHLORIDE
Excipient focus: AMMONIUM SULFATE
DOXORUBICIN HYDROCHLORIDE drug variants containing AMMONIUM SULFATE
DOXORUBICIN HYDROCHLORIDE drug variants not containing AMMONIUM SULFATE
Excipient focus: CHOLESTEROL
DOXORUBICIN HYDROCHLORIDE drug variants containing CHOLESTEROL
DOXORUBICIN HYDROCHLORIDE drug variants not containing CHOLESTEROL
Excipient focus: HISTIDINE
DOXORUBICIN HYDROCHLORIDE drug variants containing HISTIDINE
DOXORUBICIN HYDROCHLORIDE drug variants not containing HISTIDINE
Excipient focus: HYDROCHLORIC ACID
DOXORUBICIN HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
DOXORUBICIN HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxorubicin hydrochloride | 0143-9092 |
| Hikma Pharmaceuticals USA Inc | doxorubicin hydrochloride | 0143-9275 |
| Mylan Institutional LLC | doxorubicin hydrochloride | 67457-478 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED SOYBEAN LECITHIN
DOXORUBICIN HYDROCHLORIDE drug variants containing HYDROGENATED SOYBEAN LECITHIN
DOXORUBICIN HYDROCHLORIDE drug variants not containing HYDROGENATED SOYBEAN LECITHIN
Excipient focus: LACTOSE MONOHYDRATE
DOXORUBICIN HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxorubicin hydrochloride | 0143-9092 |
| Hikma Pharmaceuticals USA Inc | doxorubicin hydrochloride | 0143-9275 |
| Mylan Institutional LLC | doxorubicin hydrochloride | 67457-478 |
| >Company | >Ingredient | >NDC |
DOXORUBICIN HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT
DOXORUBICIN HYDROCHLORIDE drug variants containing N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT
DOXORUBICIN HYDROCHLORIDE drug variants not containing N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT
Excipient focus: SODIUM CHLORIDE
DOXORUBICIN HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
DOXORUBICIN HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
DOXORUBICIN HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
DOXORUBICIN HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
DOXORUBICIN HYDROCHLORIDE drug variants containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
DOXORUBICIN HYDROCHLORIDE drug variants not containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
Excipient focus: SUCROSE
DOXORUBICIN HYDROCHLORIDE drug variants containing SUCROSE
DOXORUBICIN HYDROCHLORIDE drug variants not containing SUCROSE
Excipient focus: WATER
DOXORUBICIN HYDROCHLORIDE drug variants containing WATER
DOXORUBICIN HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
